Cargando…
Placebo Response to Oral Administration in Osteoarthritis Clinical Trials and Its Associated Factors: A Model-Based Meta-analysis
IMPORTANCE: In osteoarthritis (OA) clinical trials, a placebo is often used as control. Therefore, a thorough understanding of the placebo response is important for guiding drug development in OA. OBJECTIVE: To develop an oral placebo response model for OA. DATA SOURCES: PubMed, EMBASE, and Cochrane...
Autores principales: | Wen, Xin, Luo, Jieren, Mai, Yiying, Li, Yang, Cao, Ying, Li, Zewei, Han, Shun, Fu, Quanyi, Zheng, Qingshan, Ding, Changhai, Zhu, Zhaohua, Li, Lujin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552894/ https://www.ncbi.nlm.nih.gov/pubmed/36215072 http://dx.doi.org/10.1001/jamanetworkopen.2022.35060 |
Ejemplares similares
-
A model-based quantitative analysis of efficacy and associated factors of platelet rich plasma treatment for osteoarthritis
por: Cao, Ying, et al.
Publicado: (2023) -
Relative Efficacy and Safety of Anti-Inflammatory Biologic Agents for Osteoarthritis: A Conventional and Network Meta-Analysis
por: Li, Yang, et al.
Publicado: (2022) -
Quantitative Comparison of the Clinical Efficacy of 6 Classes Drugs for IgA Nephropathy: A Model-Based Meta-Analysis of Drugs for Clinical Treatments
por: Yu, Jiesen, et al.
Publicado: (2022) -
Bone marrow lesions in osteoarthritis: From basic science to clinical implications
por: Shi, Xiaorui, et al.
Publicado: (2023) -
Latest insights in disease-modifying osteoarthritis drugs development
por: Li, Shengfa, et al.
Publicado: (2023)